Creative Planning Aclaris Therapeutics, Inc. Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$17.08 - $29.6 $302,999 - $525,104	-17,740 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$5.86 - $27.73 $16,173 - $76,534	-2,760 Reduced 13.46%	17,740 $447,000
Q4 2020 Jan 29, 2021	SELL	$2.65 - $7.61 $25,175 - $72,295	-9,500 Reduced 31.67%	20,500 $133,000
Q3 2020 Nov 05, 2020	SELL	$1.5 - $2.71 $114 - $205	-76 Reduced 0.25%	30,000 $77,000
Q3 2019 Nov 01, 2019	BUY	$0.79 - $2.47 $23,760 - $74,287	30,076 New	30,076 $32,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.